GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Current Deferred Revenue

Medicure (TSXV:MPH) Current Deferred Revenue : C$0.00 Mil (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Medicure Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Medicure's current deferred revenue for the quarter that ended in Dec. 2023 was C$0.00 Mil.

Medicure Current Deferred Revenue Historical Data

The historical data trend for Medicure's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Current Deferred Revenue Chart

Medicure Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medicure Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medicure Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Medicure's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicure (TSXV:MPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Current Deferred Revenue
Comparable Companies
XCNQ:IMCC TSXV:CANB NEOE:FH XCNQ:RVV TSXV:DHB TSXV:HASH TSX:VPH TSX:WLLW XCNQ:XTRX TSX:CTX ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
MCUJF:USA NGQ1:Germany
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Website
https://www.medicure.com
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure (TSXV:MPH) Headlines

No Headlines